Figure 2.
Figure 2. Tetramer reactivity and cytotoxicity profile of CTLs activated on HLAA2.1/AAPCs. (A) Staining with anti-CD8 (FITC-labeled, x-axis) and HLAA2.1/P495 tetramer (PE-labeled, y-axis). (B) Cytotoxicity assays performed against peptide-pulsed TAP-deficient A2.1+ T2 targets with CTLs shown above. ▪ indicates T2 cells pulsed with P495; ♦, T2 cells pulsed with irrelevant peptide. Left panels: CTLs cultured on “empty” AAPCs. Staining with P495 tetramer was lower than 0.1%. Middle panels: CTLs activated on AAPCA2P495. Right panels: CTLs activated on AAPCA2pp65. AAPCA2P495 and AAPCA2pp65 efficiently kill T2 targets pulsed with P495. Cytolysis at a given E/T ratio is higher for CTLs activated on AAPCA2pp65 compared with AAPCA2P495. Results are representative for 3 different donors.

Tetramer reactivity and cytotoxicity profile of CTLs activated on HLAA2.1/AAPCs. (A) Staining with anti-CD8 (FITC-labeled, x-axis) and HLAA2.1/P495 tetramer (PE-labeled, y-axis). (B) Cytotoxicity assays performed against peptide-pulsed TAP-deficient A2.1+ T2 targets with CTLs shown above. ▪ indicates T2 cells pulsed with P495; ♦, T2 cells pulsed with irrelevant peptide. Left panels: CTLs cultured on “empty” AAPCs. Staining with P495 tetramer was lower than 0.1%. Middle panels: CTLs activated on AAPCA2P495. Right panels: CTLs activated on AAPCA2pp65. AAPCA2P495 and AAPCA2pp65 efficiently kill T2 targets pulsed with P495. Cytolysis at a given E/T ratio is higher for CTLs activated on AAPCA2pp65 compared with AAPCA2P495. Results are representative for 3 different donors.

Close Modal

or Create an Account

Close Modal
Close Modal